Anti-Human AXL Recombinant Antibody (Humanized 11B7) (CAT#: TAB-1098CL)

The anti-AXL antibody humanized 11B7 targets AXL. The antibody can be used in the treatment of cancers, such as prostate cancer and breast cancer.


Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Fc Engineering:
  • Published Data
  • Gene Expression
  • Datasheet
  • MSDS
  • COA
FuncS

Figure 1 Orthotopic xenograft model to investigate the effects of rat anti- AXL antibodies on human prostate carcinoma growth in nude mice.

Figure 1 Orthotopic xenograft model to investigate the effects of rat anti- AXL antibodies on human prostate carcinoma growth in nude mice.

PC-3-LN prostate carcinoma cells were orthotopically implanted into the prostate of NMRI-nu/nu mice. Animals were randomized into 4 groups and received 25 mg/kg of the isotypic control antibody 1 D5 or the antagonistic rat anti-AXL antibody 11B7, as well as 40 mg/kg Sutent or 12.5 mg/kg Taxotere. During the treatment period, the growth of orthotopically growing PC-3-LN tumors as well as peripheral metastases was monitored once weekly via in vivo bioluminescence imaging on day 15, day 23, day 29, and day 34. Compared to the isotypic control antibody 1 D5, the antagonistic rat anti-AXL antibody 11B7 reduced the overall growth of PC-3-LN prostate tumors in nude mice.

FuncS

Figure 2 Orthotopic xenograft model to investigate the effects of rat anti- AXL antibodies on human prostate carcinoma metastasis in nude mice.

Figure 2 Orthotopic xenograft model to investigate the effects of rat anti- AXL antibodies on human prostate carcinoma metastasis in nude mice.

PC-3-LN prostate carcinoma cells were orthotopically implanted into the prostate of NMRI-nu/nu mice. Animals were randomized into 4 groups and received 25 mg/kg of the isotypic control antibody 1 D5 or the antagonistic rat anti-AXL antibody 11B7, as well as 40 mg/kg Sutent or 12.5 mg/kg Taxotere. Post necropsy, selected organs (liver, spleen, lung, femur, and a part of the lumbar spine) were collected and analyzed for the presence of metastases via bioluminescence imaging. Compared to the isotypic control antibody 1D5, the antagonistic rat anti-AXL antibody 11B7 reduced the occurrence of spleen metastases. Noteworthy, the anti-metastatic effect of 11 B7 in this experiment was stronger than that of Sutent.

ELISA

Figure 3 This figure describes binding activity of the rat anti-human AXL humanized antibodies h#11B7-T1 to h#11B7-T6 determined by ELISA using human AXL-Fc coated plate.

Figure 3 This figure describes binding activity of the rat anti-human AXL humanized antibodies h#11B7-T1 to h#11B7-T6 determined by ELISA using human AXL-Fc coated plate.

ELISA

Figure 4 This figure describes binding activity of the rat anti-human AXL humanized antibodies h#11B7-T7 to h#11B7-T13 determined by ELISA using human AXL-Fc coated plate.

Figure 4 This figure describes binding activity of the rat anti-human AXL humanized antibodies h#11B7-T7 to h#11B7-T13 determined by ELISA using human AXL-Fc coated plate.

ELISA

Figure 5 This figure describes binding activity of the rat anti-human AXL humanized antibodies h#11B7-T14 to h#11B7-T20 determined by ELISA using human AXL-Fc coated plate.

Figure 5 This figure describes binding activity of the rat anti-human AXL humanized antibodies h#11B7-T14 to h#11B7-T20 determined by ELISA using human AXL-Fc coated plate.

ELISA

Figure 6 This figure describes binding activity of the rat anti-human AXL humanized antibodies h#11B7-T21 to h#11B7-T27 determined by ELISA using human AXL-Fc coated plate.

Figure 6 This figure describes binding activity of the rat anti-human AXL humanized antibodies h#11B7-T21 to h#11B7-T27 determined by ELISA using human AXL-Fc coated plate.

ELISA

Figure 7 This figure describes binding activity of the rat anti-human AXL humanized antibodies h#11 B7-T28 to h#11B7-T31 determined by ELISA using human AXL-Fc coated plate (ELISA).

Figure 7 This figure describes binding activity of the rat anti-human AXL humanized antibodies h#11 B7-T28 to h#11B7-T31 determined by ELISA using human AXL-Fc coated plate (ELISA).

Figure 8 These figures describes determination of Tm of the rat anti-human AXL humanized antibodies h#11B7-T1 determined by differential scanning calorimetry (DSC).

Figure 8 These figures describes determination of Tm of the rat anti-human AXL humanized antibodies h#11B7-T1 determined by differential scanning calorimetry (DSC).


Specifications

  • Host Species
  • Human
  • Type
  • Humanized antibody
  • Specificity
  • Human
  • Clone
  • Humanized 11B7
  • Applications
  • ELISA, FuncS
  • Related Disease
  • Breast cancer, Prostate cancer

Applications

  • Application Notes
  • This antibody has been tested for use in Enzyme-linked Immunosorbent Assay and Functional Assay.

Target

  • Alternative Names
  • AXL; AXL receptor tyrosine kinase; ARK; UFO; JTK11; Tyro7

Related Resources

  • Related Diseases

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "Clone Humanized 11B7"

See other products for "AXL"

Humanized Antibody

CAT Product Name Application Type
TAB-0139CL Anti-Human AXL Recombinant Antibody (hzl613F12-24 DAR2) ELISA, IF, FC, Inhib, ICFC Humanized Antibody
TAB-0140CL Anti-Human AXL Recombinant Antibody (hzl613F12-33 DAR4) ELISA, IF, FC, Inhib, ICFC Humanized Antibody
TAB-1094CL Anti-Human AXL Recombinant Antibody (Hz1613F12) ELISA, FC, Cyt Humanized antibody
TAB-1099CL Anti-Human AXL Recombinant Antibody (Humanized 11D5) ELISA Humanized antibody
TAB-0139CL-S(P) Anti-Human AXL Recombinant Antibody scFv Fragment (hzl613F12-24 DAR2) ELISA, IF, FC, Inhib, ICFC Humanized Antibody

Chimeric Antibody

CAT Product Name Application Type
TAB-0189CL Human Anti-AXL Recombinant Antibody (TAB-0189CL) WB, FuncS, ELISA, FC Chimeric (Mouse/Human) IgG1, κ
TAB-1090CL Human Anti-AXL Recombinant Antibody (TAB-1090CL) ELISA, FuncS Chimeric (mouse/human) IgG1, κ
TAB-1091CL Human Anti-AXL Recombinant Antibody (TAB-1091CL) ADCC Chimeric (mouse/human) IgG1, κ
TAB-0189CL-S(P) Human Anti-AXL Recombinant Antibody; scFv Fragment (TAB-0189CL-S(P)) WB, FuncS, ELISA, FC Human scFv
TAB-0189CL-F(E) Human Anti-AXL Recombinant Antibody; Fab Fragment (TAB-0189CL-F(E)) WB, FuncS, ELISA, FC Chimeric (Mouse/Human) Fab

Rabbit Monoclonal Antibody

CAT Product Name Application Type
MOR-3970 Hi-Affi™ Rabbit Anti-AXL Recombinant Antibody (clone SI30DS) ELISA Rabbit IgG

Customer Reviews and Q&As

Submit a review or a question
There are currently no Customer reviews or questions for TAB-1098CL. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.

For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

© 2024 Creative Biolabs.
  • 0
  • 0
Cart

    Go to compare